What is Prime Medicine's change in deferred revenue?

Prime Medicine (PRME) reported change in deferred revenue of -$856K in Q1 2026.

How has Prime Medicine's change in deferred revenue changed year-over-year?

Prime Medicine's change in deferred revenue increased by 40.5% year-over-year, from -$1.44M to -$856K.

What does change in deferred revenue mean?

Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.

Prime Medicine PRME Change in Deferred Revenue

Change in Deferred Revenue at other companies

Intellia TherapeuticsNTLA

-$6.66M-30.7%

CRISPR TherapeuticsCRSP

-$427K+48.2%

Beam TherapeuticsBEAM

-$6.36M+14.9%

RegenxbioRGNX

-$700K-102%

Sarepta Therapeutics, Inc.SRPT

-$274.92M-222%

MeiraGTx Holdings plcMGTX

-$50K+84.8%

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's change in deferred revenue?: Prime Medicine (PRME) reported change in deferred revenue of -$856K in Q1 2026.
How has Prime Medicine's change in deferred revenue changed year-over-year?: Prime Medicine's change in deferred revenue increased by 40.5% year-over-year, from -$1.44M to -$856K.
What does change in deferred revenue mean?: Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.